This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Cross Country (CCRN) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Cross Country (CCRN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for August 7th
by Zacks Equity Research
BANR, COLM and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on August 7, 2023.
Cross Country (CCRN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare (CCRN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 13.11% and 2.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Kforce (KFRC) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Kforce (KFRC) delivered earnings and revenue surprises of -3.06% and 1.72%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boise Cascade and Cross Country Healthcare have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Boise Cascade and Cross Country Healthcare are part of the Zacks Bull and Bear of the Day article.
Bear Of The Day: Cross Country Healthcare (CCRN)
by Brian Bolan
I was shocked to see this stock with the lowest Zacks Rank considering it was a 221% winner for Stocks Under $10.
New Strong Sell Stocks for May 24th
by Zacks Equity Research
ATSG, CCRN and FSFG have been added to the Zacks Rank #5 (Strong Sell) List on May 24, 2023.
New Strong Sell Stocks for May 11th
by Zacks Equity Research
ASLE, BSET and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on May 11, 2023.
New Strong Sell Stocks for May 8th
by Zacks Equity Research
CCRN, EL and LOVE have been added to the Zacks Rank #5 (Strong Sell) List on May 8, 2023.
Cross Country Healthcare (CCRN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 10.53% and 4.91%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Insperity, Inc. (NSP) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 7.66% and 0.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Insperity, Kforce and Cross Country Healthcare
by Zacks Equity Research
Insperity, Kforce and Cross Country Healthcare have been highlighted in this Industry Outlook article.
Heidrick & Struggles (HSII) Q1 Earnings Beat Estimates
by Zacks Equity Research
Heidrick & Struggles (HSII) delivered earnings and revenue surprises of 31.03% and 2.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Staffing Services Stocks to Watch Amid Industry Headwinds
by Zacks Equity Research
The Zacks Staffing industry stands to benefit from the resumption of business activities, increased dependency on technology and benefits related to the ongoing hybrid working model. NSP, KFRC and CCRN are well poised to witness a demand surge.
Why Should Investors Hold Cross Country Healthcare (CCRN) Now?
by Zacks Equity Research
Cross Country Healthcare's (CCRN) investments in technological advancements are its success drivers.
Cross Country Healthcare (CCRN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 21.11% and 5.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Kforce, Cross Country Healthcare, HireQuest and ManpowerGroup
by Zacks Equity Research
Kforce, Cross Country Healthcare, HireQuest and ManpowerGroup are part of the Zacks top Analyst Blog.
4 Staffing Stocks to Watch on Robust January Job Additions
by Ritujay Ghosh
Stocks like Kforce Inc., (KFRC) Cross Country Healthcare, Inc. (CCRN) HireQuest, Inc. (HQI) and ManpowerGroup Inc. (MAN) are likely to benefit from robust job additions to U.S. economy.
The Zacks Analyst Blog Highlights HireQuest, Kforce, ManpowerGroup, Cross Country Healthcare and Robert Half
by Zacks Equity Research
HireQuest, Kforce, ManpowerGroup, Cross Country Healthcare and Robert Half are included in this Analyst Blog.
Insperity, Inc. (NSP) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 32.97% and 1.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Blowout Jobs Report a Boon for These 5 Staffing Stocks
by Tirthankar Chakraborty
Invest in staffing stocks like HireQuest (HQI), Kforce (KFRC), ManpowerGroup (MAN), Cross Country Healthcare (CCRN) & Robert Half International (RHI), banking on solid January jobs growth.
Kforce (KFRC) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Kforce (KFRC) delivered earnings and revenue surprises of 1.09% and 0.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?